Actavis Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Parsippany NJ United States (2012)
Status: Acquired by Allergan PLC (2015) (2015) → now AbbVie (2019)

Organization Overview

First Clinical Trial
2012
NCT00864305
First Marketed Drug
2012
mestranol
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ACTAVIS ELIZABETH | Actavis Group | ACTAVIS GRP PTC | Actavis Inc. | ACTAVIS INC | ACTAVIS LABS | ACTAVIS LABS FL | ACTAVIS LABS FL INC | ACTAVIS LABS NY INC | ACTAVIS LABS UT INC | ACTAVIS LLC | ACTAVIS MID ATLANTIC | Actavis Mid-Atlantic LLC | ACTAVIS PHARMA | ACTAVIS TOTOWA | ACTAVIS TOTOWA TEVA | Durata Therapeutics International BV (an Affiliate of Actavis, Inc.) | Forest Laboratories, Inc. a subsidiary of Actavis plc | Forest Research Institute, a subsidiary of Actavis plc.